Interstitial and orphan lung disease

Molecular endpoints for establishing target engagement by novel idiopathic pulmonary fibrosis therapies
Paul J. Wolters, Vincent Cottin

European Respiratory Journal Mar 2019, 53 (3) 1900283; DOI: 10.1183/13993003.00283-2019
The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study
Sebastiano Emanuele Torrisi, Brett Ley, Michael Kreuter, Marlies Wijsenbeek, Eric Vittinghoff, Harold R. Collard, Carlo Vancheri

European Respiratory Journal Mar 2019, 53 (3) 1801587; DOI: 10.1183/13993003.01587-2018
Procedure volume and mortality after surgical lung biopsy in interstitial lung disease
Jolene H. Fisher, Shane Shapera, Teresa To, Theodore K. Marras, Andrea Gershon, Sharon Dell

European Respiratory Journal Feb 2019, 53 (2) 1801164; DOI: 10.1183/13993003.01164-2018
Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study
Claire M. Nolan, Matthew Maddocks, Toby M. Maher, Winston Banya, Suhani Patel, Ruth E. Barker, Sarah E. Jones, Peter M. George, Paul Cullinan, William D-C. Man

European Respiratory Journal Feb 2019, 53 (2) 1801186; DOI: 10.1183/13993003.01186-2018
Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes
Raphael Borie, Diane Bouvry, Vincent Cottin, Clement Gauvain, Aurélie Cazes, Marie-Pierre Debray, Jacques Cadranel, Philippe Dieude, Tristan Degot, Stephane Dominique, Anne Sophie Gamez, Madeleine Jaillet, Pierre-Antoine Juge, Arturo Londono-Vallejo, Arnaud Mailleux, Hervé Mal, Catherine Boileau, Christelle Menard, Hilario Nunes, Gregoire Prevot, Sebastien Quetant, Patrick Revy, Julie Traclet, Lidwine Wemeau-Stervinou, Marie Wislez, Caroline Kannengiesser, Bruno Crestani

European Respiratory Journal Feb 2019, 53 (2) 1800508; DOI: 10.1183/13993003.00508-2018
No relevant pharmacokinetic drug–drug interaction between nintedanib and pirfenidone
Luca Richeldi, Sophie Fletcher, Huzaifa Adamali, Nazia Chaudhuri, Sabrina Wiebe, Sven Wind, Kathrin Hohl, Andrew Baker, Rozsa Schlenker-Herceg, Susanne Stowasser, Toby M. Maher

European Respiratory Journal Jan 2019, 53 (1) 1801060; DOI: 10.1183/13993003.01060-2018
Predicting outcomes in rheumatoid arthritis related interstitial lung disease
Joseph Jacob, Nikhil Hirani, Coline H.M. van Moorsel, Srinivasan Rajagopalan, John T. Murchison, Hendrik W. van Es, Brian J. Bartholmai, Frouke T. van Beek, Marjolijn H.L. Struik, Gareth A. Stewart, Maria Kokosi, Ryoko Egashira, Anne Laure Brun, Gary Cross, Joseph Barnett, Anand Devaraj, George Margaritopoulos, Ronald Karwoski, Elisabetta Renzoni, Toby M. Maher, Athol U. Wells

European Respiratory Journal Jan 2019, 53 (1) 1800869; DOI: 10.1183/13993003.00869-2018
SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)
Ganesh Raghu, Luca Richeldi, Bruno Crestani, Peter Wung, Raphael Bejuit, Corinne Esperet, Christian Antoni, Christina Soubrane

European Respiratory Journal Dec 2018, 52 (6) 1801130; DOI: 10.1183/13993003.01130-2018
Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study
Sabrina Bajwah, Joanna M. Davies, Hanan Tanash, David C. Currow, Adejoke O. Oluyase, Magnus Ekström

European Respiratory Journal Dec 2018, 52 (6) 1801278; DOI: 10.1183/13993003.01278-2018
Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis
Grazyna Kwapiszewska, Anna Gungl, Jochen Wilhelm, Leigh M. Marsh, Helene Thekkekara Puthenparampil, Katharina Sinn, Miroslava Didiasova, Walter Klepetko, Djuro Kosanovic, Ralph T. Schermuly, Lukasz Wujak, Benjamin Weiss, Liliana Schaefer, Marc Schneider, Michael Kreuter, Andrea Olschewski, Werner Seeger, Horst Olschewski, Malgorzata Wygrecka

European Respiratory Journal Nov 2018, 52 (5) 1800564; DOI: 10.1183/13993003.00564-2018

Main menu

User menu

Search

Interstitial and orphan lung disease

Pages

Contact us